Los Angeles, CA9 Active Studies

Chronic Kidney Disease Clinical Trials in Los Angeles, CA

Find 9 actively recruiting chronic kidney disease clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

9
Active Trials
7
Sponsors
955
Enrolling

Recruiting Chronic Kidney Disease Studies in Los Angeles

About Chronic Kidney Disease Clinical Trials in Los Angeles

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 9 chronic kidney disease clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 955 participants. Research is being sponsored by Bayer, University of California, Los Angeles, Renibus Therapeutics, Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in Los Angeles — FAQ

Are there chronic kidney disease clinical trials in Los Angeles?

Yes, there are 9 chronic kidney disease clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 9 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated July 18, 2026 from ClinicalTrials.gov